Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Recruiting · NCT00898313 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Blood drawUrine collectionbiologic sample preservation procedurecomparative genomic hybridizationfine needle aspiration of the lungfluorescence bronchoscopy with airway biopsygene expression microarray analysisnasal brushingproteomic profiling analysissputum samplethoracentesis
What this trial is about
RATIONALE: Using samples of blood, urine, sputum, and lung tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular predictors of cancer in patients at high risk of lung cancer.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- All adults referred to Vanderbilt Medical Center, Veterans Administration Medical Center, St. Thomas Hospital and Meharry Medical Center for evaluation of signs or symptoms of lung cancer.
Exclusion criteria
- Inability to provide informed consent
- Minors
- Pregnant women
Where it is running
2 locations listed across 1 US state.
- Vanderbilt-Ingram Cancer Center - Nashville, Tennessee, United States
- Veterans Affairs Medical Center - Nashville - Nashville, Tennessee, United States